Drug information for LENTE INSULIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100 UNITS/ML
Discontinued
INSULIN ZINC SUSP BEEF
Insulin, Long-Acting
NOVO NORDISK INC
17998
INJECTABLE; INJECTION
40 UNITS/ML
Discontinued
INSULIN ZINC SUSP BEEF
Insulin, Long-Acting
NOVO NORDISK INC
"
Drug Adverse Effects information for LENTE INSULIN
Role code
Indications
Reaction
# Reports
C
ANTICOAGULANT THERAPY
APHASIA
3
C
ANTICOAGULANT THERAPY
COAGULATION TIME PROLONGED
3
C
ANTICOAGULANT THERAPY
CONVULSION
3
C
ANTICOAGULANT THERAPY
DIABETES MELLITUS
3
C
ANTICOAGULANT THERAPY
EPISTAXIS
3
C
ANTICOAGULANT THERAPY
HEPARIN-INDUCED THROMBOCYTOPENIA
3
C
ANTICOAGULANT THERAPY
HEPATIC FAILURE
3
C
ANTICOAGULANT THERAPY
HYPERHIDROSIS
3
C
ANTICOAGULANT THERAPY
HYPOTENSION
3
C
ANTICOAGULANT THERAPY
MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION
3
C
ANTICOAGULANT THERAPY
METASTASES TO LUNG
3
C
ANTICOAGULANT THERAPY
MOBILITY DECREASED
3
C
ANTICOAGULANT THERAPY
NAUSEA
3
C
ANTICOAGULANT THERAPY
ORGAN FAILURE
3
C
ANTICOAGULANT THERAPY
PHARYNGEAL OEDEMA
3
C
ANTICOAGULANT THERAPY
PULMONARY EMBOLISM
3
C
ANTICOAGULANT THERAPY
RENAL CELL CARCINOMA
3
C
ANTICOAGULANT THERAPY
RENAL FAILURE
3
C
ANTICOAGULANT THERAPY
UNRESPONSIVE TO STIMULI
3
C
ANTICOAGULANT THERAPY
VOMITING
3
C
CONVULSION
APHASIA
1
C
CONVULSION
COAGULATION TIME PROLONGED
1
C
CONVULSION
CONVULSION
1
C
CONVULSION
DIABETES MELLITUS
1
C
CONVULSION
EPISTAXIS
1
C
CONVULSION
HEPARIN-INDUCED THROMBOCYTOPENIA
1
C
CONVULSION
HEPATIC FAILURE
1
C
CONVULSION
HYPERHIDROSIS
1
C
CONVULSION
HYPOTENSION
1
C
CONVULSION
MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION
1
C
CONVULSION
METASTASES TO LUNG
1
C
CONVULSION
MOBILITY DECREASED
1
C
CONVULSION
NAUSEA
1
C
CONVULSION
ORGAN FAILURE
1
C
CONVULSION
PHARYNGEAL OEDEMA
1
C
CONVULSION
PULMONARY EMBOLISM
1
C
CONVULSION
RENAL CELL CARCINOMA
1
C
CONVULSION
RENAL FAILURE
1
C
CONVULSION
UNRESPONSIVE TO STIMULI
1
C
CONVULSION
VOMITING
1
C
PRODUCT USED FOR UNKNOWN INDICATION
APHASIA
18
C
PRODUCT USED FOR UNKNOWN INDICATION
COAGULATION TIME PROLONGED
18
C
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
18
C
PRODUCT USED FOR UNKNOWN INDICATION
DIABETES MELLITUS
18
C
PRODUCT USED FOR UNKNOWN INDICATION
EPISTAXIS
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPARIN-INDUCED THROMBOCYTOPENIA
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FAILURE
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERHIDROSIS
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTENSION
18
C
PRODUCT USED FOR UNKNOWN INDICATION
MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION
18
C
PRODUCT USED FOR UNKNOWN INDICATION
METASTASES TO LUNG
18
C
PRODUCT USED FOR UNKNOWN INDICATION
MOBILITY DECREASED
18
C
PRODUCT USED FOR UNKNOWN INDICATION
NAUSEA
18
C
PRODUCT USED FOR UNKNOWN INDICATION
ORGAN FAILURE
18
C
PRODUCT USED FOR UNKNOWN INDICATION
PHARYNGEAL OEDEMA
18
C
PRODUCT USED FOR UNKNOWN INDICATION
PULMONARY EMBOLISM
18
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL CELL CARCINOMA
18
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE
18
C
PRODUCT USED FOR UNKNOWN INDICATION
UNRESPONSIVE TO STIMULI
18
C
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
18
C
PULMONARY EMBOLISM
APHASIA
3
C
PULMONARY EMBOLISM
COAGULATION TIME PROLONGED
3
C
PULMONARY EMBOLISM
CONVULSION
3
C
PULMONARY EMBOLISM
DIABETES MELLITUS
3
C
PULMONARY EMBOLISM
EPISTAXIS
3
C
PULMONARY EMBOLISM
HEPARIN-INDUCED THROMBOCYTOPENIA
3
C
PULMONARY EMBOLISM
HEPATIC FAILURE
3
C
PULMONARY EMBOLISM
HYPERHIDROSIS
3
C
PULMONARY EMBOLISM
HYPOTENSION
3
C
PULMONARY EMBOLISM
MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION
3
C
PULMONARY EMBOLISM
METASTASES TO LUNG
3
C
PULMONARY EMBOLISM
MOBILITY DECREASED
3
C
PULMONARY EMBOLISM
NAUSEA
3
C
PULMONARY EMBOLISM
ORGAN FAILURE
3
C
PULMONARY EMBOLISM
PHARYNGEAL OEDEMA
3
C
PULMONARY EMBOLISM
PULMONARY EMBOLISM
3
C
PULMONARY EMBOLISM
RENAL CELL CARCINOMA
3
C
PULMONARY EMBOLISM
RENAL FAILURE
3
C
PULMONARY EMBOLISM
UNRESPONSIVE TO STIMULI
3
C
PULMONARY EMBOLISM
VOMITING
3
Ads by Google